EMILY LANGLOIS: Open Payments
NPI 1922496090 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,484 in 139 payments from 20 companies in 2025. Trend: 2023 $1,722 · 2024 $2,676 · 2025 $2,484
Food & beverage: $2,392Education: $92
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 32 | $434 |
| Janssen Biotech, Inc. | 14 | $318 |
| Novartis Pharmaceuticals Corporation | 15 | $307 |
| ABBVIE INC. | 14 | $304 |
| UCB, Inc. | 18 | $279 |
| E.R. Squibb & Sons, L.L.C. | 13 | $167 |
| GENZYME CORPORATION | 5 | $120 |
| AstraZeneca Pharmaceuticals LP | 5 | $110 |
| GlaxoSmithKline, LLC. | 4 | $87 |
| SOBI, INC | 3 | $55 |
Products named: TREMFYA, Bimzelx, COSENTYX, RINVOQ, KRYSTEXXA, ORENCIA, ENBREL, KEVZARA.
Industry payments across KY — which companies pay providers there.
